Exclusion Criteria:~* Women of child bearing potential.~* History or presence of a seizure disorder.~* History
of peptic ulcer disease, urinary or gastric retention; asthma or obstructive pulmonary disease.~* History or
presence of bladder outflow obstruction, gastrointestinal obstructive disorder or reduced GI motility, or
narrow-angle glaucoma.~* History or presence of gastrointestinal, hepatic, or renal disease, or other condition
known to interfere with the absorption, distribution, metabolism or excretion of drugs.~* History or presence
of myasthenia.~* Known hypersensitivity to donepezil, solifenacin or related drugs.~* Any other clinically
relevant acute or chronic diseases which could interfere with patients' safety during the trial, or expose them
to undue risk, or which could interfere with study objectives.~* Patients who have participated in another
clinical trial with an investigational drug within previous 30 days.
